Join us on Wednesday, April 17th for Curebound Connects: Artificial Intelligence + Cancer. More info here.

[object Object]

CURES IN
OUR LIFETIME

Accelerating cancer research into cures

Curebound is a San Diego-based 501c3 philanthropic organization that raises and invests strategic funding in translational cancer research projects aimed at accelerating new discoveries to clinical application.

Curebound
Curebound

About Us

Curebound is headquartered in San Diego amidst a unique combination of three NCI-cancer centers, clinical care hospitals, biotech companies, venture capital investors, philanthropic networks, and most importantly- a regional culture that embraces the spirit of collaboration.

This ecosystem positions San Diego and Curebound at the forefront of discovery - bringing genomic medicine, new technologies and clinical trials to market and presents an unprecedented opportunity for research collaboration. We believe that the next decade will be critical to the development of sophisticated, personalized approaches in the way we prevent, treat and ultimately find cures for cancer.

Curebound is committed to investing $100 million into collaborative cancer research in San Diego to make the vision of cures in our lifetime a reality.

Our Mission

Mobilize San Diego to accelerate cures for cancer in our lifetime.

Curebound

CANCER IS RELENTLESS.

WE MUST BE TOO.

Background

Launched in 2021, Curebound united two highly respected cancer organizations, Padres Pedal the Cause and Immunotherapy Foundation, both of which were founded by families whose lives were changed by cancer.

Padres Pedal the Cause was founded by Bill Koman, a two-time lymphoma survivor, and his wife Amy. Deeply grateful for the life-saving care that Bill received, the Koman family is committed to ensuring the same outcome for others. In 2013, Amy and Bill Koman created Padres Pedal the Cause, a cancer fundraising cycling challenge operated in partnership with the San Diego Padres that has raised $20+ million for early-phase research in San Diego.

‘Padres Pedal’ is an outgrowth of Pedal the Cause St. Louis (founded by the Komans in 2009), which has raised and donated over $40 million to fund 169 innovative research grants at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. The Koman family also established the Cancer Frontier Fund in partnership with the Barnes-Jewish Hospital Foundation and worked to create the Illumination Gala, which has become the gold standard for this type of signature event, having raised $35+ million on its own over the last decade. Collectively, these efforts have raised close to $95 million dollars for cancer research across the country, which has led to millions more in follow-on funding from additional grant sources.

In 2015, Ralph and Fernanda Whitworth established the Immunotherapy Foundation (IF) to accelerate precision cancer immunotherapy research into better treatments for patients. A year later, Ralph lost his battle with cancer, but his vision lives on through IF’s work. In just six years, IF contributed over $5.5M to promising cancer research, cancer prevention and patient support initiatives. Funds from IF helped to seed and operationalize the Advanced Cell Therapy Lab and enabled the creation of the San Diego Center for Precision Immunotherapy, both as UC San Diego. IF was instrumental in establishing a cutting-edge neoantigen discovery platform with multiple therapeutic applications, including two first-in-kind Phase I clinical trials- a personalized cancer vaccine and personalized cell therapy. In addition, IF worked to create an HPV cancer prevention curriculum for community health workers and supported cancer immunotherapy summits for patients and caregivers.

These two organizations share the belief that cures are possible. Curebound is a bold step toward realizing that vision. To support the vision of a world without cancer, please consider making a donation today.

Curebound

SCIENTIFIC
ADVISORY BOARD

JOHN HOOD, Ph.D., Chairperson CEO, Endeavor Biomedicines

JOHN HOOD, Ph.D., Chairperson

CEO, Endeavor Biomedicines

Read More
PAULA ARISTIZABAL, MD, MAS Pediatric Hematologist/Oncologist, Rady Children’s Hospital San Diego

PAULA ARISTIZABAL, MD, MAS

Pediatric Hematologist/Oncologist, Rady Children’s Hospital San Diego

Read More
EZRA COHEN, MD, FRCPSC, FASCO Chief Science Advisor, Curebound

EZRA COHEN, MD, FRCPSC, FASCO

Chief Science Advisor, Curebound

Read More
CHRISTIAN DIMAANO, Ph.D., MPH   Vice President, Medical Affairs at Lassen Therapeutics

CHRISTIAN DIMAANO, Ph.D., MPH

Vice President, Medical Affairs at Lassen Therapeutics

Read More
BRENDAN ECKELMAN, Ph.D. Co-founder, Chief Science Officer and Executive Vice President of Inhibrx

BRENDAN ECKELMAN, Ph.D.

Co-founder, Chief Science Officer and Executive Vice President of Inhibrx

Read More
JON EDWARDS, Ph.D. undefined

JON EDWARDS, Ph.D.

Read More
RICH HEYMAN, Ph.D. Partner, ARCH Venture Partners

RICH HEYMAN, Ph.D.

Partner, ARCH Venture Partners

Read More
NANCY HONG, Ph.D. undefined

NANCY HONG, Ph.D.

Read More
MITCHELL KRONENBERG, Ph.D. Chief Scientific Officer, La Jolla Institute for Immunology

MITCHELL KRONENBERG, Ph.D.

Chief Scientific Officer, La Jolla Institute for Immunology

Read More
ANDREW LAM, Pharm.D. Senior Vice President, Ally Bridge Group

ANDREW LAM, Pharm.D.

Senior Vice President, Ally Bridge Group

Read More
SCOTT LIPPMAN, MD Senior Associate Dean and Associate Vice Chancellor for Cancer Research and Care, Moores Cancer Center at UC San Diego Health

SCOTT LIPPMAN, MD

Senior Associate Dean and Associate Vice Chancellor for Cancer Research and Care, Moores Cancer Center at UC San Diego Health

Read More
MONAL MEHTA, Ph.D. Therapeutics Analyst on the Avidity Partners

MONAL MEHTA, Ph.D.

Therapeutics Analyst on the Avidity Partners

Read More
ZE'EV RONAI, Ph.D. Director, Sanford Burnham Prebys Cancer Center; Jeanne and Gary Herberger Leadership Chair in Cancer Research

ZE'EV RONAI, Ph.D.

Director, Sanford Burnham Prebys Cancer Center; Jeanne and Gary Herberger Leadership Chair in Cancer Research

Read More
REUBEN SHAW, Ph.D. Director, Salk Institute Cancer Center Professor of Molecular and Cell Biology Laboratory William R. Brody Chair

REUBEN SHAW, Ph.D.

Director, Salk Institute Cancer Center Professor of Molecular and Cell Biology Laboratory William R. Brody Chair

Read More
COURT R. TURNER, JD Partner, LYZZ Capital

COURT R. TURNER, JD

Partner, LYZZ Capital

Read More
ASHLEY VAN ZEELAND, Ph.D. MBA VP, Corporate and Business Development

ASHLEY VAN ZEELAND, Ph.D. MBA

VP, Corporate and Business Development

Read More
TRAVIS YOUNG, Ph.D. VP Biologics, Calibr at Scripps Research

TRAVIS YOUNG, Ph.D.

VP Biologics, Calibr at Scripps Research

Read More
Curebound

BOARD OF
DIRECTORS

Bill Koman, Chairperson CEO, Koman Group; Founder, Padres Pedal the Cause

Bill Koman, Chairperson

CEO, Koman Group; Founder, Padres Pedal the Cause

Read More
Cheryl A.M. Anderson, Ph.D., MPH, MS Professor and Dean, Herbert Wertheim School of Public Health and Human Longevity Science

Cheryl A.M. Anderson, Ph.D., MPH, MS

Professor and Dean, Herbert Wertheim School of Public Health and Human Longevity Science

Read More
Donald Ankeny President and CEO, Westcore

Donald Ankeny

President and CEO, Westcore

Read More
Laurence H. Bloch Private Investor & Former Chairman TransWestern Publishing Company

Laurence H. Bloch

Private Investor & Former Chairman TransWestern Publishing Company

Read More
Mark Cafferty CEO, San Diego Regional  Economic Development Corporation

Mark Cafferty

CEO, San Diego Regional Economic Development Corporation

Read More
Aaron Davis CEO, Boxer Capital

Aaron Davis

CEO, Boxer Capital

Read More
Rich Heyman, Ph.D. Partner at ARCH Venture Partners

Rich Heyman, Ph.D.

Partner at ARCH Venture Partners

Read More
John Hood, Ph.D. CEO, Endeavor Biomedicines

John Hood, Ph.D.

CEO, Endeavor Biomedicines

Read More
Catriona Jamieson, MD, Ph.D. Deputy Director, UC San Diego Moores Cancer Center Professor of Medicine and Chief, Division of Regenerative Medicine

Catriona Jamieson, MD, Ph.D.

Deputy Director, UC San Diego Moores Cancer Center Professor of Medicine and Chief, Division of Regenerative Medicine

Read More
Donald B. Kearns, M.D., M.M.M.  President Emeritus, Rady Children’s Hospital

Donald B. Kearns, M.D., M.M.M.

President Emeritus, Rady Children’s Hospital

Read More
Julie Tafel Klaus Retired Publishing/ Philanthropist

Julie Tafel Klaus

Retired Publishing/ Philanthropist

Read More
Anne Marbarger CEO, Curebound

Anne Marbarger

CEO, Curebound

Read More
Magda Margquet, Ph.D. Co - Founder of AltheaDX and ALMA Life Sciences, LLC

Magda Margquet, Ph.D.

Co - Founder of AltheaDX and ALMA Life Sciences, LLC

Read More
Daniel J. Ryan Co-Chief Investment Officer and Regional Market Director of San Diego - Alexandria Real Estate Equities, Inc.

Daniel J. Ryan

Co-Chief Investment Officer and Regional Market Director of San Diego - Alexandria Real Estate Equities, Inc.

Read More
ROB SINGH President & CEO, CONAM

ROB SINGH

President & CEO, CONAM

Read More
Robin Toft Global Life Sciences & Boardroom Diversity Advisor | ZRG Partners, LLC

Robin Toft

Global Life Sciences & Boardroom Diversity Advisor | ZRG Partners, LLC

Read More
Christian F. Tresse Principal, Bernstein Private Wealth Management

Christian F. Tresse

Principal, Bernstein Private Wealth Management

Read More
Court R. Turner, JD Partner, LYZZ Capital Advisors

Court R. Turner, JD

Partner, LYZZ Capital Advisors

Read More
Fernanda Whitworth Founder, Immunotherapy Foundation

Fernanda Whitworth

Founder, Immunotherapy Foundation

Read More
Malin Burnham, Advisory Chairman, Burnham Foundation

Malin Burnham, Advisory

Chairman, Burnham Foundation

Read More
Jay Levitt, Honorary CEO, Lofta Inc.

Jay Levitt, Honorary

CEO, Lofta Inc.

Read More
Curebound

CUREBOUND
TEAM

ANNE MARBARGER

Chief Executive Officer

EZRA COHEN, M.D.

Chief Science Advisor

KAREN HOOPER

Chief Strategy and Implementation Officer

CLARE MCGOWAN, PH.D.

Senior Director of Research

KATE SINCLAIR

Communications + Creative Director
Executive Producer, Concert for Cures

HEATHER DEAN-PRESNALL

Strategic Philanthropy Officer

SHANNON GILL

Community Engagement Director

MEGAN WADDELL

Padres Pedal the Cause Event Director

DANI DAWSON

Chief Development Officer

LIZ DIGERONIMO

Padres Pedal the Cause Senior Manager

RAHUL SARIPALLI

Research & Operations Associate

ADAM WILLIAMS

Marketing & Communications Manager

KYLE HARKER

Event Operations Coordinator

RYLEE JOHNSON

Community Engagement Coordinator

Curebound

PARTNERS AND
SPONSORS

Curebound is proud to partner with these corporate leaders who share a commitment to creating a world without cancer. Together, we can go further, move faster and do more to accelerate cures for patients today.

undefined undefined
undefined undefined
Curebound

IN KIND PARTNERS

undefined undefined
undefined undefined
undefined undefined
Curebound

EXPLORATION

Curebound
Curebound

ACCELERATION

Curebound
Curebound

COLLABORATION

Curebound
Curebound

CURES